ACC 2022: Late-breaking Science Video Collection

Published: 05 April 2022

  • Views:

    Views Icon 5329

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise analysis of the late-breaking science results and spotlight impactful data. 

For a deeper dive into key clinical trial data, Dr Harriette Van Spall (McMaster University, Hamilton, CA)talks with principal investigators in her regular Late-Breaker Discussion Series. 

Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.

More from this programme

Part 1

View from the Thoraxcenter

In this concise episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their analysis of the late-breaking trials that will be presented at ACC 2022.
2 sessions
ACC 22 Late-breaking Science Preview Watch now
ACC.22 Late-breaking Science Wrap-Up Watch now

Part 2

Late-breaker Discussion Series

Host, Dr Harriette Van Spall interviews the late-breaker presenters of ACC Scientific Sessions 2022.
4 sessions
ACC 2022 Late-breaker Discussion: The SODIUM-HF Trial Watch now
ACC 2022 Late-breaker Discussion: The SuperWIN Trial Watch now
ACC 22 Late-breaker Discussion: The PROMPT-HF Trial Watch now
ACC 22 Late-breaker Discussion: The DIAMOND Trial Watch now

Part 3

Expert Interviews

19 sessions
ACC 22: Findings from the VALOR-HCM Trial Watch now
ACC 22: MAVA-LTE Shows Improvement in NYHA Class in Patients Treated with Mavacamten Watch now
ACC 22: Results From the PACIFIC AF Trial Watch now
ACC 22: FAME 3 Suggests CABG Outperforms FFR-Guided PCI in Patients with Multivessel Disease Watch now
ACC 22: Results from the TRANSLATE-TIMI 70 Trial Watch now
ACC 22: Results from the POISE-3 Trial Watch now
ACC 22: ICD Shock Therapies and the Burden of Ventricular Tachycardia Watch now
ACC 22: PACMAN-AMI Shows Reduced Plaque Regression in AMI Patients Treated with Alirocumab Watch now
ACC 22: Magnitude & Duration of Effects of a siRNA Targeting Lp(a) Watch now
ACC 22: Results From a sub-study of the POISE-3 Trial Watch now
ACC 22: Findings from the CoreValve US Pivotal & SURTAVI Trials Watch now
ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR Watch now
ACC 22: Results From the Chocolate-Touch Study Watch now
ACC 22: Results from the GIPS-IV Trial Watch now
ACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial Watch now
ACC 22: Results From the EMPULSE Study – Empagliflozin Proves Beneficial for Patients With HF Watch now
ACC 22: Secondary Analysis of CANTOS Finds LDL & HDL Predict Residual Risk of Atherosclerotic Events Watch now
ACC 22: 3-year Efficacy Outcomes from the SPYRAL HTN-ON MED Med Pilot Study Watch now
2022 AHA/ACC/HFSA Guideline for HF Management: Highlights & Implementation Watch now

Part 4

Late-breaking Highlights

3 sessions
ACC 22: 3 Trials That Will Change Your Practice with Dr Purvi Parwani Watch now
ACC 22: 5 Trials That Will Change Your Practice with Interventionalist, Dr Mirvat Alasnag Watch now
4 Lipid Late-breaker Highlights from ACC.22 with Dr Erin Michos Watch now

Faculty Biographies

Harriette Van Spall

Harriette Van Spall

Associate Professor of Medicine, Director of E-Health and Virtual Care

Dr Harriette Van Spall is an Associate Professor of Medicine and cardiologist and serves as Director of E-Health at McMaster University, Canada. She completed her medical and postgraduate clinical training at the University of Toronto and earned a Master of Public Health degree at Harvard University, US. Dr Van Spall is a Canadian Institutes of Health Research-funded clinical trialist and researcher with a focus on heart failure, health services, and health disparities.

She has garnered more than $4 million in research funding, has won several research awards, and has published her work in high-impact medical journals. She is an invited speaker, media correspondent, and editorial board member active in peer review at several high-impact medications journals and grant funding agencies, including Canadian Institutes of Health Research and Heart and Stroke Foundation of Canada.

Dr Van Spall is an Editorial Board…

View full profile
Gregg C Fonarow

Gregg C Fonarow

Professor and Clinical Co-Chief of Cardiology

Personal History

Dr Gregg Curtis Fonarow is a Cardiologist and Professor based in the Los Angeles area. 

 

Academic History

In 1987, he obtained his M.D. from the University of California Los Angeles David Geffen School of Medicine. He then completed his internship, residency and fellowship between 1988-1993 at the UCLA School of Medicine.1

His research interests centre on heart failure management, preventative cardiology, disease management and implementing treatment systems to improve clinical outcome.1

 

Career Overview

Dr Fonarow serves as Co-Chief of UCLA's Division of Cardiology, Director of the Ahmanson-UCLA Cardiomyopathy Center, and Co-director of UCLA's Preventative Cardiology Program.1, 2

In 2003, he became Professor of Medicine and was awarded the Eliot Corday…

View full profile
Tariq Ahmad

Tariq Ahmad

Chief of Heart Failure

Dr Tariq Ahmad is Chief of Heart Failure at Yale University School of Medicine.

Dr Ahmad is a cardiologist who specialises in treating patients with end-stage heart failure and heart transplants. He also cares for patients with cardiomyopathies, which are diseases of the heart muscle, and advanced valvular diseases. 

View full profile